Zealand Pharma A/S
http://www.zealandpharma.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Zealand Pharma A/S
Scrip M&A Podcast: Which Companies Could Be Acquired Next?
The editorial team from Scrip discusses the M&A potential of various emerging biopharmas, such as Viking, Verona, Altimmune, Xenon and Crinetics.
End Game: Adrenomed Targets Global Reach For Sepsis Candidate
German biotech Adrenomed has proof-of-concept data showing its sepsis drug can cut mortality by 67%. Now, it needs money to move the candidate into Phase IIb/III trials.
Clasp Launches With $150m To Develop Personalized T-Cell Engagers
Clasp Therapeutics, which emerged from labs at Johns Hopkins University and was incubated by a pair of venture capital investors, plans to achieve a clinical trial readout with its series A cash.
Crinetics May Have Drug Profile To Take Leading Position In Acromegaly
Reporting a second positive Phase III trial for oral paltusotine, Crinetics plans an NDA later this year to position its drug against competing injectable somatostatin analogs.
Company Information
- Industry
- Pharmaceuticals
- Other Names / Subsidiaries
-
- Encycle Therapeutics, Inc.
- Valeritas Holdings, Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice